Abstract
OBJECTIVE: Physicians may use several validated risk indices to estimate perioperative cardiac risk, but there is little evidence for interventions to reduce this risk. We were interested in evaluating how general internists assess, define, communicate, and attempt to modify perioperative cardiac risk.
DESIGN: Cross-sectional survey of all 312 general internists in the Canadian Society of Internal Medicine with Canadian mailing addresses; 117 (38%) responded.
RESULTS: Respondents’ mean age was 46 years, 79% were male, and on average they did 17 preoperative consults per month. Of the 104 respondents who routinely performed preoperative assessments, 96% (100/104) informed patients of their perioperative cardiac risk, but 77% did so only subjectively (i.e., stating risk as low, moderate, or high). Respondents provided 8, 27, and 12 different definitions for low, moderate, and high risk, respectively, with marked variability in the range of definitions they provided: from <1% to <20% for “low risk,” from 1% to 2% to 20% to 50% for “moderate risk,” and from >2% to >50% for “high risk.” The 67% of respondents who reported using a perioperative cardiac risk index used a variety of indices and exhibited just as much variability in their risk estimates and definitions as those who didn’t use risk indices. While virtually all advised perioperative β blockade in patients with known coronary artery disease, they varied substantially in the recommended agent or dose; further, these internists were evenly split on whether antiplatelet agents should be held or continued perioperatively.
CONCLUSIONS: These physicians differed widely in their assessment of perioperative cardiac risk and their definitions of low, moderate, or high risk. This raises concerns about whether patients (and surgeons) are provided with adequate information to make fully informed decisions about the potential risks of elective surgical operations.
References
Mangano DT, Goldman L. Preoperative assessment of patients with known or suspected coronary disease. N Engl J Med. 1995;333:1750–6.
Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977;297:845–50.
Detsky AS, Abrams HB, McLaughlin JR, et al. Predicting cardiac complications in patients undergoing noncardiac surgery. J Gen Intern Med. 1986;1:211–9.
Eagle KA, Coley CM, Newell JB, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med. 1989;110:859–66.
L’Italien GH, Paul SD, Hendel RC, et al. Development and validation of a Bayesian model for perioperative cardiac risk assessment in a cohort of 1801 vascular surgical candidates. J Am Coll Cardiol. 1996;27:779–86.
Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043–9.
American College of Physicians. Clinical guideline, part I. Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. Ann Intern Med. 1997;127:309–12.
Palda VA, Detsky AS. Clinical guideline, part II. Perioperative assessment and management of risk from coronary artery disease. Ann Intern Med. 1997;127:313–28.
Eagle KA, Brundage BH, Chaitman BR, et al. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol. 1996;27:910–48.
McAlister FA, Graham I, Karr GW, Laupacis A. Evidence-based medicine and the practicing clinician. J Gen Intern Med. 1999;14:236–42.
Devereaux PJ, Ghali WA, Gibson NE, et al. Physicians’ recommendations for patients undergoing noncardiac surgery. Clin Invest Med. 2000;23:116–23.
Devereaux PJ, Ghali WA, Gibson NE, et al. Physician estimates of perioperative cardiac risk in patients undergoing noncardiac surgery. Arch Intern Med. 1999;159:713–17.
O’Connor AM, Rostom A, Fiset V, et al. Decision aids for patients facing health treatment of screening decisions: systematic review. BMJ. 1999;319:731–4.
Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med. 1996;335:1713–20.
Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med. 1999;341:1789–94.
Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep venous thrombosis with low-dose aspirin: Pulmonary Embolism Prevention (PEP) Trial. Lancet. 2000;355:1295–302.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
Drs. McAlister, Ghali, and Khan are supported by the Alberta Heritage Foundation for Medical Research; Dr. Ghali is also supported by a Government of Canada Research Chair; Dr. Devereaux is supported by the Heart and Stroke Foundation of Canada/Canadian Institutes of Health Research.
Rights and permissions
About this article
Cite this article
Taher, T., Khan, N.A., Devereaux, P.J. et al. Assessment and reporting of perioperative cardiac risk by canadian general internists. J GEN INTERN MED 17, 933–936 (2002). https://doi.org/10.1046/j.1525-1497.2002.11230.x
Issue Date:
DOI: https://doi.org/10.1046/j.1525-1497.2002.11230.x